Dong-A ST Co., Ltd.: Diabetes Mellitus, Type 2 trials
The registry lists 13 Diabetes Mellitus, Type 2 studies with Dong-A ST Co., Ltd. as lead sponsor. 0 are open to participants now and 0 have results posted.
Phase 1 4Phase 3 5Phase 4 3No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of DA5221-T When Added to Ongoing DA5221-B1 and DA5221-B2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic ControlActive, not recruitingNCT06290349Phase 3
- A Clinical Trial to Evaluate the Preference Regarding Convenience of Medication and Efficacy/Safety of SUGAMET®XR Tablet 5/1000mgStatus unknownNCT04653779Phase 4
- Efficacy and Safety of Dapagliflozin When Added to Ongoing Metformin and Evogliptin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic ControlCompletedNCT04356742Phase 3
- Observational Study to Evaluate the Efficacy and Safety of Suganon Tab. or Sugamet XR Tab.Status unknownNCT04326166
- Efficacy and Safety of Evogliptin When Added to Ongoing Metformin and Dapagliflozin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic ControlCompletedNCT04170998Phase 3
- Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver DiseasesCompletedNCT03910361Phase 4
- A Study to Evaluate the Safety, Tolerability, PK and PD of DA-1241 in Healthy Male Subjects and Subjects With T2DMCompletedNCT03646721Phase 1
- A Study To Evaluate The Safety,Tolerability, PK and PD Of DA-1241 In Healthy Male SubjectsCompletedNCT03061981Phase 1
- Phase IV Clinical Trial to Investigate the Effect on Blood Glucose of Evogliptin in Patients With Type 2 Diabetes(EVERGREEN)CompletedNCT02974504Phase 4
- Efficacy and Safety of Evogliptin add-on to Metformin in Patients With type2 DiabetesCompletedNCT02949193Phase 3
- A Clinical Trial to Investigate the Efficacy and Safety of EvogliptinCompletedNCT02946541Phase 3
- A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01(Evogliptin/Metformin XR 2.5/500 mg x 2 Tablets) Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg in Healthy Male VolunteersCompletedNCT02375139Phase 1
- A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01 Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg, and to Evaluate the Effect of Food on the Pharmacokinetics of DA-1229_01 in Healthy Male VolunteersCompletedNCT02167061Phase 1